Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joaquín Lasierra-Cirujeda"'
Autor:
M Gimeno, P Coronel, M. J. Aza Pascual-Salcedo, Lasala-Aza C, Joaquín Lasierra-Cirujeda, Lasierra-Ibañez A, M. M. Aza Pascual Salcedo
Publikováno v:
Journal of Biosciences and Medicines. :102-128
Stress, inflammation and Plasminogen activator inhibitor 1 (PAI-1) are key mechanisms throughout the development of aging, constituting a crossroad in the most frequent pathologies that accompany it. Among metabolic processes, obesity, metabolic synd
Autor:
María Mercedes Aza Pascual-Salcedo, Joaquín Lasierra-Cirujeda, María José Aza Pascual-Salcedo
Publikováno v:
World Journal of Cardiovascular Diseases. :54-71
The purpose of this prospective study is to determine the relative incidence of Alzheimer’s disease in patients treated for at least three years, with sulodexide (n = 46, 76.48 ± 7.02 years old) or acenocoumarol (n = 47, 78.21 ± 6.66 years old) i
Aging: Thromboembolic Disease, Metabolic Syndrome, Type 2 Diabetes Mellitus, and Alzheimer’s Disease
Autor:
Carmen Lasala Aza, Joaquín Lasierra-Cirujeda, María José Aza Pascual-Salcedo, María Mercedes Aza Pascual-Salcedo, Alicia Lasierra-Ibañez
Publikováno v:
Journal of Biosciences and Medicines. :1-20
Aging can be interpreted as an unavoidable process whose end point is the death. Aging entails, in the hemostasis field, some changes that favour blood hypercoagulability. Both the plasminogen activator inhibitor (PAI-1), specific inhibitor of the ti